Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 23.6

(0.85%)

Total Debt Summary of Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.'s latest annual total debt in 2023 was 154.34 Million TWD , up 201.51% from previous year.
Welgene Biotech Co.,Ltd.'s latest quarterly total debt in 2024 Q2 was 152.11 Million TWD , up 3.39% from previous quarter.
Welgene Biotech Co.,Ltd. reported annual total debt of 51.19 Million TWD in 2022, up 114.7% from previous year.
Welgene Biotech Co.,Ltd. reported annual total debt of 23.84 Million TWD in 2021, down -18.84% from previous year.
Welgene Biotech Co.,Ltd. reported quarterly total debt of 152.11 Million TWD for 2024 Q2, up 3.39% from previous quarter.
Welgene Biotech Co.,Ltd. reported quarterly total debt of 154.34 Million TWD for 2023 FY, up 201.51% from previous quarter.

Annual Total Debt Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Total Debt of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year	Total Debt	Total Debt Growth
2023	154.34 Million TWD	201.51%
2022	51.19 Million TWD	114.7%
2021	23.84 Million TWD	-18.84%
2020	29.37 Million TWD	-33.68%
2019	44.29 Million TWD	216.01%
2018	14.01 Million TWD	-62.71%
2017	37.58 Million TWD	24.08%
2016	30.29 Million TWD	-13.53%
2015	35.03 Million TWD	-29.47%
2014	49.67 Million TWD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	147.12 Million TWD	-4.68%
2024 Q2	152.11 Million TWD	3.39%
2023 FY	154.34 Million TWD	201.51%
2023 Q3	129.93 Million TWD	-3.67%
2023 Q4	154.34 Million TWD	18.79%
2023 Q1	72.39 Million TWD	41.42%
2023 Q2	134.87 Million TWD	86.32%
2022 Q3	13.31 Million TWD	24.88%
2022 Q2	10.66 Million TWD	-52.89%
2022 Q1	22.63 Million TWD	-5.06%
2022 FY	51.19 Million TWD	114.7%
2022 Q4	51.19 Million TWD	284.4%
2021 Q1	30.42 Million TWD	3.55%
2021 Q3	18.07 Million TWD	-46.63%
2021 Q4	23.84 Million TWD	31.93%
2021 FY	23.84 Million TWD	-18.84%
2021 Q2	33.86 Million TWD	11.31%
2020 Q4	29.37 Million TWD	-13.06%
2020 FY	29.37 Million TWD	-33.68%
2020 Q3	33.79 Million TWD	-0.2%
2020 Q2	33.85 Million TWD	0.0%
2020 Q1	- TWD	-100.0%
2019 Q2	16.48 Million TWD	0.0%
2019 Q1	16.48 Million TWD	17.59%
2019 FY	44.29 Million TWD	216.01%
2019 Q4	44.29 Million TWD	0.0%
2018 Q4	14.01 Million TWD	0.0%
2018 FY	14.01 Million TWD	-62.71%
2018 Q1	27.67 Million TWD	-26.39%
2018 Q2	27.67 Million TWD	0.0%
2018 Q3	14.01 Million TWD	-49.34%
2017 Q2	31.49 Million TWD	9.97%
2017 Q1	28.63 Million TWD	-5.48%
2017 Q4	37.58 Million TWD	13.19%
2017 Q3	33.2 Million TWD	5.45%
2017 FY	37.58 Million TWD	24.08%
2016 FY	30.29 Million TWD	-13.53%
2016 Q4	30.29 Million TWD	17.41%
2016 Q3	25.8 Million TWD	0.0%
2015 FY	35.03 Million TWD	-29.47%
2014 FY	49.67 Million TWD	0.0%

Peer Total Debt Comparison of Welgene Biotech Co.,Ltd.

Name	Total Debt	Total Debt Difference
BIONET Corp.	45.01 Million TWD	-242.887%
DIVA Laboratories, Ltd.	2.53 Million TWD	-5995.853%
Genetics Generation Advancement Corp.	49.29 Million TWD	-213.096%
Puriblood Medical Co., Ltd.	51.64 Million TWD	-198.885%
TFBS Bioscience Inc.	131.77 Million TWD	-17.132%